U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Partnerships: Enhancing Science Through Collaborations With FDA
  4. FDA Memoranda of Understanding
  5. Domestic MOUs
  6. MOU-225-05-2001
  1. Domestic MOUs

MOU-225-05-2001

MEMORANDUM OF UNDERSTANDING ON ENVIRONMENTAL CONTAMINANTS IN FISH
AND SHELLFISH BETWEEN THE U.S. FOOD AND DRUG ADMINISTRATION'S CENTER
FOR FOOD SAFETY AND APPLIED NUTRITION AND THE U.S. ENVIRONMENTAL
PROTECTION AGENCY'S OFFICE OF WATER

Purpose: To continue a high level of collaboration between the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition (FDA/CFSAN), and the U.S. Environmental Protection Agency's Office of Water (EPA/OW) regarding the activities intended to address 1) environmental contaminants in fish and shellfish, and 2) the safety of fish and shellfish for consumption by U.S. consumers. As to these matters, FDA/CFSAN and EPA/OW commit to work closely with each other to coordinate, in advance of action, activities that are of mutual interest under each organization's respective mission. This MOU will provide a mechanism for this coordination and collaboration under each organization's respective mission.

Missions: One of the missions of the FDA is to promote and protect the public health by ensuring that the nation's food supply, including commercial fish and shellfish, is safe, sanitary, wholesome, and properly labeled. The EPA's mission is to protect human health and the environment. To help achieve this mission, the EPA Office of Water's goals are to restore and maintain water quality in order to protect human health and ecosystems, and to provide the public with information on how best to reduce their water-related risks, including risks pertaining to the consumption of noncommercial fish and shellfish.

Goals and Objectives: FDA/CFSAN and EPA/OW acknowledge our responsibilities to serve as leaders in promoting and protecting public health while carrying out our agencies' missions. Close cooperation, collaboration, and interaction between the two agencies will help ensure a more unified U.S. Government message regarding the risks and benefits of consuming commercial and noncommercial fish and shellfish that will be clear and beneficial to people in the U.S. Goals and objectives associated with this partnership will be achieved by:

  • Promoting the use of the best available science and public health policies;
  • Promoting the sharing and availability of appropriate information among the agencies' health and environmental professionals and the public;
  • Encouraging environmental monitoring efforts by FDA/CFSAN and EPA/OW and stakeholders;
  • Encouraging the development of public health advice that considers both risks and benefits of consumption of commercial and noncommercial fish and shellfish; and
  • Promoting uniformity where appropriate in public health messages regarding consumption of commercial and noncommercial fish and shellfish.

Scope: This agreement builds upon collaborative efforts already underway within and between FDA/CFSAN and EPA/OW. FDA/CFSAN and EPA/OW will strive to incorporate the above goals and objectives that are results oriented and, when appropriate, involve interested stakeholders. This MOU establishes a mechanism for cooperation and coordination of public health issues associated with commercial and noncommercial fish and shellfish.

Interagency Communications: FDA/CFSAN and EPA/OW will establish a framework for coordination and communication pertaining to this MOU and to promote staff exchange, as appropriate, for improved interagency communications. EPA/OW and FDA/CFSAN will each identify a representative to serve as its central point of contact on matters relating to this MOU. The representative will participate in regular meetings to facilitate this MOU, coordinate research, and avoid unnecessary duplication in order to increase efficiency. These points of contact will be used to provide input on FDA/CFSAN and EPA/OW matters regarding contaminants in fish and shellfish, when such matters are of mutual interest and in accordance with the existing statutory or regulatory authorities, rights, requirements, or responsibilities assigned to the FDA/CFSAN and EPA/OW. In addition, FDA/CFSAN and EPA/OW will promote staff exchange, as appropriate, for improved interagency communications. Finally, FDA/CFSAN and EPA/OW will develop, within six months of signing this MOU and periodically thereafter, a joint plan that describes planned collaborative activities.

Qualifications and Limitations: This MOU is neither a fiscal nor a funds obligation document, nor does it supplement either EPA's or FDA's existing statutory authorities. All commitments under this MOU made by EPA/OW and FDA/CFSAN are subject to the availability of appropriations. Nothing in this MOU, in and of itself, obligates FDA/CFSAN or EPA/OW to expend appropriations or to enter into any contract, assistance agreement, interagency agreement, or other financial obligations. Any endeavor involving reimbursement or contribution of funds between the parties to this MOU or the sharing of non-public information will be set forth in an Interagency Agreement (IAG) or other appropriate agreement entered into under applicable statutes, regulations and policies. The activities, initiatives, or pilot projects contemplated in this MOU will be carried out in accordance with the existing statutory authorities and nothing in this MOU will, in any way, alter the specific statutory or regulatory authorities, rights, requirements, or responsibilities assigned to the FDA/CFSAN, EPA/OW, or other agencies. This MOU does not create any rights or benefits for any third parties, substantive or procedural, enforceable by law or equity against FDA/CFSAN or EPA/OW, their officers or employees, or any other person. This MOU does not direct or apply to any person outside FDA/CFSAN and EPA/OW. Neither FDA/CFSAN nor EPA/OW may endorse the purchase or sale of products and services provided by specific commercial entities as part of this effort.

Authority: For EPA: Clean Water Act Section 104, NEPA Section 102(2)(0), For FDA: Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 393.

Period of Agreement: This MOU will become effective when approved by the indicated signatories for the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition and the U.S Environmental Protection Agency's Office of Water and will continue in effect for five years. Either party may terminate this MOU by providing written notice to the other party. The termination will be effective upon the sixtieth calendar day following notice, unless a later date is set forth. The parties agree to evaluate the MOU at least once in the five-year period of the MOU at which time the parties may agree to continue, modify, or cancel the MOU.

 

/s/
JOEL BEAUVAIS
Deputy Assistant Administrator
Office of Water
U.S. Environmental Protection Agency
Date: 07/07/2016

 

/s/
STEPHEN M. OSTROFF, M.D.
Deputy Commissioner
Office of Foods and Veterinary Medicine
U.S. Food and Drug Administration
Date: 08/02/2016

 


MOU 225-05-2001 Amendment Number 1

MEMORANDUM OF UNDERSTANDING BETWEEN U.S. DEPARTMENT OF HEALTH AND
HUMAN SERVICES U.S. FOOD AND DRUG ADMINISTRATION CENTER FOR FOOD
SAFETY AND APPLIED NUTRITION AND U.S. ENVIRONMENTAL PROTECTION
AGENCY’S OFFICE OF WATER

This is amendment number one (1) to the Memorandum of Understanding (MOU) 225-05-2001 between the U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition, and the U.S. Environmental Protection Agency’s Office of Water.

The purpose of this amendment is to extend the expiration date from August 2, 2021, as noted below. This is permissible under Period of Agreement. Execution of this amendment provides continuity to promote collaboration and enhance knowledge and efficiency by providing for the sharing of information of mutual concern between the Parties. All other content, terms, and conditions stated in MOU Number 225-05-2001, executed on August 2, 2016, will remain unchanged.

This agreement, when accepted by the undersigned, will have an effective period of performance from the date of the last signature until five years from that date and may be modified or terminated by mutual written consent by both parties or may be terminated by either party upon a thirty-day advance written notice to the other.

 

APPROVED AND ACCEPTED BY:

 

/s/
Susan T. Mayne, Ph.D. Director
Center for Food Safety and Applied Nutrition
U.S. Food and Drug Administration
Date: 04/29/2022

 

APPROVED AND ACCEPTED BY:

 

/s/
Deborah G. Nagle
Director, Office of Science and Technology
Office of Water
U.S. Environmental Protection Agency
Date: 05/12/2022

Back to Top